azibiot
krka, d.d., novo mesto - azitromicinas - plėvele dengtos tabletės - 500 mg - azithromycin
azibiot
krka, d.d., novo mesto - azitromicinas - milteliai geriamajai suspensijai - 20 mg/ml; 250 mg; 40 mg/ml - azithromycin
klerimed
medochemie ltd. - klaritromicinas - plėvele dengtos tabletės - 250 mg; 500 mg - clarithromycin
fromilid
krka, d.d., novo mesto - klaritromicinas - granulės geriamajai suspensijai - 125 mg/5 ml; 250 mg/5 ml - clarithromycin
fromilid
krka, d.d., novo mesto - klaritromicinas - plėvele dengtos tabletės - 250 mg; 500 mg - clarithromycin
fromilid uno
krka, d.d., novo mesto - klaritromicinas - modifikuoto atpalaidavimo tabletės - 500 mg - clarithromycin
caspofungin sandoz
sandoz d.d. - kaspofunginas - milteliai infuzinio tirpalo koncentratui - 50 mg - caspofungin
caspofungin sandoz
sandoz d.d. - kaspofunginas - milteliai infuzinio tirpalo koncentratui - 70 mg - caspofungin
inrebic
bristol myers squibb pharma eeig - fedratinib dihydrochloride monohydrate - myeloproliferative disorders; primary myelofibrosis - antinavikiniai vaistai - inrebic is indicated for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis, post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis who are janus associated kinase (jak) inhibitor naïve or have been treated with ruxolitinib.
extrotan
egis pharmaceuticals plc - atorvastatinas/ezetimibas - kietosios kapsulės - 10 mg/10 mg - atorvastatin and ezetimibe